HNB
PTX

Huntington National Bank’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Huntington National Bank’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-126
Closed -$14K – 1803
2016
Q1 		$14K Buy
+126
New +$2.5K ﹤0.01% 1428
2015
Q2 		– Sell
-126
Closed -$14K – 1865
2015
Q1 		$14K Sell
126
-53
-30% -$5.05K ﹤0.01% 1436
2014
Q4 		$17K Buy
+179
New +$17.1K ﹤0.01% 1386

Other funds holding PTX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Huntington National Bank's PTX Position: Q2 2016 in Review

Huntington National Bank sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q2 2016, closing a stake of 126 shares — an estimated $14K sold.

Huntington National Bank first reported a position in PTX in Q4 2014 and held it in 3 quarters. The position peaked at $17K in Q4 2014. 56 funds tracked by Wall St. Rank hold PTX as of Q2 2016.

  • Huntington National Bank reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q2 2016 after selling out during the quarter.
  • Huntington National Bank sold 126 Pernix Therapeutics Holdings, Inc. shares in Q2 2016, an estimated $14K.
  • Huntington National Bank first reported a position in Pernix Therapeutics Holdings, Inc. in Q4 2014 and held it in 3 quarters.
  • Huntington National Bank's Pernix Therapeutics Holdings, Inc. position peaked at $17K in Q4 2014.
  • 56 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q2 2016.

Based on Huntington National Bank's 13F filing for Q2 2016, filed 25 Jul 2016.